Malate Dehydrogenase (MDH)

Malate Dehydrogenase (MDH) is an enzyme that plays a key role in cellular metabolism and belongs to the NAD-dependent dehydrogenase family. Malate Dehydrogenase (MDH) catalyzes the reversible conversion between malate and oxaloacetate. There are multiple subtypes of MDH. In eukaryotes, there are mainly cytoplasmic MDH1, mitochondrial MDH2, and MDH present in peroxisomes, glyoxysomes, and chloroplasts; there is only one MDH in prokaryotes such as Escherichia coli. MDH1 is closely related to the proliferation and survival of tumor cells, and its high expression is associated with a poor prognosis of non-small cell lung cancer. MDH1 plays an important role in replenishing cytoplasmic NAD to support glycolysis during cell proliferation, and together with lactate dehydrogenase (LDH), maintains the intracellular NAD supply; in cardiovascular disease research, it was found that changes in its activity are related to energy metabolism, oxidative stress and other processes in cardiac tissue. In addition, MDH participates in important metabolic pathways such as the tricarboxylic acid cycle, gluconeogenesis, and amino acid synthesis, and plays a role in different cellular compartments. For example, MDH transports reducing equivalents between the cytoplasm and mitochondria through the malate-aspartate shuttle, maintaining cellular energy metabolism and normal physiological functions[1][2][3][4][5][6].

By Effects: Inhibitor (4)
共 4种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
MDH1-IN-1

MDH1-IN-1 是一种选择性 MDH1 抑制剂,对人源靶点的 IC50 为 6.79 μM,具有体内抗肿瘤功效,可用于结直肠癌的研究。

2143463-31-2
Inhibitor
99.97%
MDH1-IN-1
MDH1-IN-2

MDH1-IN-2 (Compound 7c) 是一种选择性 MDH1 抑制剂,对 MDH1 和 MDH2 的 IC50 分别为 2.27 和 27.47 μM,其通过抑制 MDH1 介导的 2-Ketoglutaric acid (MS-Z45936) 向 α-Hydroxyglutaric acid (MS-W37837) 转化来减少 ROS 生成,进而抑制 2-Ketoglutaric acid (MS-Z45936) 诱导的铁死亡 (ferroptosis)。

2143463-35-6
Inhibitor
98.70%
MDH1-IN-2
MDH1/2-IN-1

MDH1/2-IN-1 是一种 MDH1/2 抑制剂(IC50 分别为 1.07 μM 和 1.06 μM),可抑制线粒体呼吸和 HIF-1α 通路,显示出显著的抗肿瘤潜力,为开发靶向癌症代谢的药物提供了新的方向。

2143473-95-2
Inhibitor
98.78%
MDH1/2-IN-1
MDH2-IN-2

MDH2-IN-2 是一种具有口服活性的 MDH2 抑制剂(IC50 为 5.9 μM),可降低哺乳动物细胞模型中的衰老标志物水平和衰老相关分泌表型 (SASP) 因子,延长秀丽隐杆线虫的寿命并改善其健康寿命,缓解衰老小鼠的组织衰老并抑制 SASP 因子、恢复肝肾功能,可用于衰老相关研究。

3047410-41-0
Inhibitor
MDH2-IN-2

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础